(MedPage Today) — Two adalimumab biosimilars (Amjevita and Imraldi) worked as well for moderate to severe psoriasis as the original brand-name product (Humira) for patients either starting or switching treatment, according to real-world data from…
Source link : https://www.medpagetoday.com/dermatology/psoriasis/114532
Author :
Publish date : 2025-03-06 22:45:00
Copyright for syndicated content belongs to the linked Source.
